A multicenter, randomized, phase II study of cisplatin, etoposide, and gemcitabine or cisplatin plus gemcitabine as first-line treatment in patients with poor-prognosis small cell lung carcinoma

Filippo De Marinis, Fabrizio Nelli, Marco Lombardo, Francesco Ferraú, Santi Barbera, Oscar Bertetto, Sandro Barni, Giovanni Michetti, Roberto Labianca, Cesare Gridelli

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'A multicenter, randomized, phase II study of cisplatin, etoposide, and gemcitabine or cisplatin plus gemcitabine as first-line treatment in patients with poor-prognosis small cell lung carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences